BioCentury

1:47 AM GMT, Jan 29, 2014
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Financial News

Dicerna, Celladon, Eagle amend IPOs

RNAi play Dicerna Pharmaceuticals Inc. (Watertown, Mass.), gene therapy company Celladon Corp. (San Diego, Calif.) and drug delivery company Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.) all amended planned IPOs on NASDAQ. Dicerna bumped up

Read the full 340 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.